Autophagy In Skeletal Muscle Research Articles

Transcriptional Regulation by Nuclear Corepressors and PGC-1α: Implications for Mitochondrial Quality Control and Insulin Sensitivity

The peroxisome proliferator-activated receptors (PPARs) and estrogen-related receptor (ERRα) are ligand-activated nuclear receptors that coordinately regulate gene expression. Recent evidence suggests that nuclear corepressors, NCoR, RIP140, and SMRT, repress nuclear receptors-mediated transcriptional activity on specific promoters, and thus regulate insulin sensitivity, adipogenesis, mitochondrial number, and activity in vivo. Moreover, the coactivator PGC-1α that increases mitochondrial biogenesis during exercise and calorie restriction directly regulates autophagy in skeletal muscle and mitophagy in the pathogenesis of Parkinson's disease. In this paper, we discuss the PGC-1α's novel role in mitochondrial quality control and the role of nuclear corepressors in regulating insulin sensitivity and interacting with PGC-1α.

Activation of autophagy and suspended apoptosis in skeletal muscle of inclusion body myositis

Inclusion Body Myositis (IBM) is characterized by rimmed vacuole formation and misfolded protein accumulation, both depending on lysosome dysfunction. In skeletal muscle, selective protein degradation is allowed by macroautophagy. A proper balance in degradation and accumulation of proteins and organelles is critical for cell survival. Extracellular signal-regulated protein kinase (ERK1/2) is essential in cell survival, but recent evidence suggests that it is also necessary for autophagy. Alteration in subcellular localization of ERK promotes cell death either via autophagic death or via apoptosis upstream caspase-3. Moreover, in IBM myocytes there is no convincing evidence for apoptosis. Here, we correlated the expression level of autophagic and apoptotic molecules with that of ERK2 by analysing, with immunohistochemistry (IHC) and western blot (WB) methods, immunolocalization and expression of a panel of molecules directly involved and/or associated with the disease histopathogenesis: coated vesicles protein clathrin, mannose-6-phosphate receptor (M6PR), autophagy related proteins Beclin1 and ATG5, microtubule associated protein light chain LC3a and LC3b, Apoptotic Protease Activating Factor 1 (APAF1), Caspase-3, ERK2, and the specific IBM marker SMI31. Muscle biopsy specimens were obtained from 10 patients with sporadic IBM, 1 familial IBM patient, 1 amyotrophic lateral sclerosis patient, 1 patient with polymyositis with prominent mitochondrial pathology and 9 non myophatic patients as control specimens. IHC studies of expression and colocalization revealed an increase of clathrin, Beclin1, ATG5, and LC3 immunoreactivity, mainly observed in the sarcoplasm of small, atrophic fibres in all diseased specimens compared to controls. By WB analysis, expression level of both APAF1 and Caspase-3 did not significantly change between patients and controls, whereas the level of expression of ERK2 and autophagy markers seemed to inversely correlate. The results demonstrated that transport of newly synthesized lysosome enzymes and formation of autophagic vacuoles are both activated in IBM muscle. ERK2 phosphorylating activity is probably involved in rescue attempt to overcome the cell injury rather than directly stimulating the cell death. During IBM, the apoptotic cascade seems to be suspended, however,under the effect of cytotoxic stimuli, protective autophagy may switch to autophagic programmed cell death.

The role of TRAIL in mediating autophagy in myositis skeletal muscle: A potential nonimmune mechanism of muscle damage

Multinucleated cells are relatively resistant to classic apoptosis, and the factors initiating cell death and damage in myositis are not well defined. We hypothesized that nonimmune autophagic cell death may play a role in muscle fiber damage. Recent reports indicate that TRAIL may induce both NF-κB activation and autophagic cell death in other systems. We undertook this study to investigate the role of TRAIL in cell death and pathogenesis in vitro and in vivo, using myositis muscle tissues from humans and mice. Gene expression profiling was performed in myositis patient and control muscle specimens. Immunohistochemistry analysis was performed to confirm the gene array findings. We also analyzed TRAIL-induced cell death (apoptosis and autophagy) and NF-κB activation in vitro in cultured cells. TRAIL was expressed predominantly in myositis muscle fibers, but not in biopsy specimens from normal or other dystrophic-diseased muscle. Autophagy markers were up-regulated in humans with myositis and in mouse models of myositis. TRAIL expression was restricted to regenerating/atrophic areas of muscle fascicles, blood vessels, and infiltrating lymphocytes. TRAIL induced NF-κB activation and IκB degradation in cultured cells that are resistant to TRAIL-induced apoptosis but that undergo autophagic cell death. Our data demonstrate that TRAIL is expressed in myositis muscle and may mediate both activation of NF-κB and autophagic cell death in myositis. Thus, this nonimmune pathway may be an attractive target for therapeutic intervention in myositis.

Doxorubicin Administration Increases Markers of Autophagy in Skeletal Muscle

Doxorubicin is an effective antitumor agent used in cancer treatment. However, doxorubicin can also cause muscle toxicity and can result in significant reduction in skeletal muscle mass and function. The mechanism(s) by which doxorubicin induces toxicity in skeletal muscle is unclear. However, doxorubicin-induced toxicity is associated with increased generation of reactive oxygen species and oxidative damage within muscle fibers. In this regard, autophagy can be induced by oxidative stress and it is also a constitutively active catabolic process that degrades oxidized proteins. PURPOSE: We hypothesized that systemic doxorubicin administration in rats would promote increased autophagy in skeletal muscle as evidenced by increased components of the autophagy system. METHODS: To test this postulate, adult, male Sprague-Dawley rats were randomly assigned to placebo or doxorubicin groups. The doxorubicin animals received doxorubicin hydrochloride (20 mg/kg body weight IP) 24 hours prior to sacrifice, whereas the placebo groups received saline injections. The soleus muscles were excised and used for biochemical analyses. RESULTS: Doxorubicin administration resulted in increased levels of mRNA and protein abundance of proteins involved in autophagy. Specifically, the mRNA levels of cathepsin L (+3.6±0.2), LC3 (+1.7±0.3), beclin (+3.5±0.6), and ATG12 (+3.4±0.5) were significantly (p<0.05) elevated in soleus muscle following doxorubicin administration. Also, the protein levels of cathepsin L (+1.5±0.1) and beclin (+1.4±0.1) were significantly (p<0.05) elevated in soleus muscle isolated from animals treated with doxorubicin. CONCLUSION: These findings demonstrate that doxorubicin administration increases the expression of several key autophagy regulatory genes in skeletal muscle. These increases suggest that autophagy is upregulated in skeletal muscle following doxorubicin administration and may lead to a reduction in skeletal muscle mass and function.

Mitochondrial dynamic remodeling in strenuous exercise-induced muscle and mitochondrial dysfunction: Regulatory effects of hydroxytyrosol

Physical exercise is considered to exert a positive effect on health, whereas strenuous or excessive exercise (Exe) causes fatigue and damage to muscle and immune functions. The underlying molecular mechanisms are still unclear. We designed a protocol to mimic Exe and explore the ensuing cellular damage and involvement of mitochondrial dynamics. We found that Exe was prone to decrease endurance capacity and induce damage to renal function and the immune system. Muscle atrophy markers atrogin-1 and MuRF1 mRNA were increased by Exe, accompanied by increased autophagy and mitochondrial fission in skeletal muscle. Exe caused a decrease in PGC-1α and complex I expression; it also activated JNK and Erk1/2 pathways and consequently induced p53, p21, and MnSOD expression in skeletal muscle. The involvement of oxidant-induced autophagy and mitochondrial dysfunction was confirmed in C2C12 myoblasts. Hydroxytyrosol (HT), a natural olive polyphenol, efficiently enhanced endurance capacity and prevented Exe-induced renal and immune system damage. Also, HT treatment inhibited both the Exe-induced increase in autophagy and mitochondrial fission and the decrease in PGC-1α expression. In addition, HT enhanced mitochondrial fusion and mitochondrial complex I and II activities in muscle of Exe rats. These results demonstrate that Exe-induced fatigue and damage to muscle and immune functions may be mediated via the regulation of mitochondrial dynamic remodeling, including the downregulation of mitochondrial biogenesis and upregulation of autophagy. HT supplementation may regulate mitochondrial dynamic remodeling and enhance antioxidant defenses and thus improve exercise capacity under Exe conditions.

Autophagy in Skeletal Muscle is Required for Exercise Training-Induced Improvement in Glucose Tolerance

Autophagy in Skeletal Muscle is Required for Exercise Training-Induced Improvement in Glucose Tolerance

Effect of Gait &amp; Step Training on Markers of Skeletal Muscle Autophagy in Parkinson's Disease Patients

Effect of Gait &amp; Step Training on Markers of Skeletal Muscle Autophagy in Parkinson's Disease Patients

An in vivo and in vitro assessment of autophagy-related gene expression in muscle of rainbow trout (Oncorhynchus mykiss)

In mammals, new evidence has demonstrated the important role of the autophagic/lysosomal pathway in regulating muscle mass and identified the transcription factor FoxO3 as a key factor of the control of this proteolytic system by inducing several autophagy-related genes. In contrast, the mechanisms responsible for the regulation of autophagy have not been investigated in teleosts, known to exhibit different muscle growth dynamics. The present work aimed to characterize both in vivo and in vitro the transcriptional regulation of several major genes involved in autophagy (LC3B, gabarapl1, atg12l, atg4b) in the white skeletal muscle of rainbow trout. We found that fasting fish for 14days or serum depletion of trout myocytes strongly induces the expression of all studied genes. Our in vitro study on trout myocytes indicated that IGF1 induces FoxO3 phosphorylation but has a low or no effect on autophagy-related gene expression, suggesting a moderate role for this transcription factor on the autophagic/lysosomal pathway in this species. Data reported here show for the first time in a lower vertebrate, the existence and the regulation of several major genes involved in the autophagy, opening a new area of research on the molecular bases of muscle protein degradation in teleosts.

Mitochondrial fission and remodelling contributes to muscle atrophy

Mitochondria are crucial organelles in the production of energy and in the control of signalling cascades. A machinery of pro-fusion and fission proteins regulates their morphology and subcellular localization. In muscle this results in an orderly pattern of intermyofibrillar and subsarcolemmal mitochondria. Muscular atrophy is a genetically controlled process involving the activation of the autophagy-lysosome and the ubiquitin-proteasome systems. Whether and how the mitochondria are involved in muscular atrophy is unknown. Here, we show that the mitochondria are removed through autophagy system and that changes in mitochondrial network occur in atrophying muscles. Expression of the fission machinery is per se sufficient to cause muscle wasting in adult animals, by triggering organelle dysfunction and AMPK activation. Conversely, inhibition of the mitochondrial fission inhibits muscle loss during fasting and after FoxO3 overexpression. Mitochondrial-dependent muscle atrophy requires AMPK activation as inhibition of AMPK restores muscle size in myofibres with altered mitochondria. Thus, disruption of the mitochondrial network is an essential amplificatory loop of the muscular atrophy programme.

Increased contractile acitivity induces autophagy in skeletal muscle

Contractile activity is essential in maintaining and promoting the oxidative phenotype of fatigue resistance, metabolic flexibility, insulin sensitivity and resistance to oxidative stress in skeletal muscle. This requires constant remodeling of structural proteins and organelles (e.g. mitochondria). We therefore hypothesized that autophagy, a catabolic process involved in the degradation of long‐lived proteins and organelles, is enhanced by increased contractile activity (i.e. endurance exercise). We submitted adult mice (12‐wk old, C57BL6) to 28 days of voluntary wheel running and used sedentary mice as controls (n=10/group). The expression of proteins associated with autophagosome formation (Beclin 1, LC3‐I+LC3‐II), mitochondrial autophagy (Bnip3), and aggregate protein degradation (p62/SQSTM1) were measured in the exercise‐recruited plantaris muscles. Consistent with our hypothesis, exercise training resulted in significant induction of Beclin1 (33%), Bnip3 (41.5%), LC3‐I+LC3‐II (43%) and LC3‐II‐to‐LC3‐I ratio (210%), and reduction of p62 (24%). The same directional changes were observed when tonic, oxidative soleus muscles were compared with phasic, glycolytic white vastus muscles in sedentary mice. Our findings suggest a role for autophagy in contractile activity‐mediated maintenance and promotion of oxidative phenotype in skeletal muscle.This study was funded by NIH Grant AR050429 (Zhen Yan).

Autophagy in skeletal muscle: implications for Pompe disease

Pompe disease is caused by an inherited deficiency of acid a-glucosidase (GAA), a lysosomal enzyme that catalyzes the breakdown of glycogen to glucose. In the absence of GAA, enlarged, glycogen-laden lysosomes accumulate in multiple tissues, although the major clinical manifestations are seen in cardiac and skeletal muscle. For many years, it was believed that the rupture of glycogen-filled lysosomes was the major cause of the profound muscle damage observed in patients with Pompe disease. Here, we present evidence that a failure of productive autophagy in muscle tissue contributes strongly to disease pathology in both patients with Pompe disease and GAA-knockout mice. In the GAA-knockout mouse model, progressive accumulation of autophagic vesicles is restricted to Type II-rich muscle fibers. Not only does this build-up of autophagosomes disrupt the contractile apparatus in the muscle fibers, it also interferes with enzyme replacement therapy by acting as a sink for the recombinant enzyme and preventing its efficient delivery to the lysosomes. Our data indicate that a re-examination of the presumed pathological mechanism in Pompe disease is necessary, and suggest that successful treatment of patients with Pompe disease will require consideration of the dramatic failure of autophagy that occurs in this disease.

Autophagy Is Required to Maintain Muscle Mass

The ubiquitin-proteasome and autophagy-lysosome pathways are the two major routes for protein and organelle clearance. In skeletal muscle, both systems are under FoxO regulation and their excessive activation induces severe muscle loss. Although altered autophagy has been observed in various myopathies, the specific role of autophagy in skeletal muscle has not been determined by loss-of-function approaches. Here, we report that muscle-specific deletion of a crucial autophagy gene, Atg7, resulted in profound muscle atrophy and age-dependent decrease in force. Atg7 null muscles showed accumulation of abnormal mitochondria, sarcoplasmic reticulum distension, disorganization of sarcomere, and formation of aberrant concentric membranous structures. Autophagy inhibition exacerbated muscle loss during denervation and fasting. Thus, autophagy flux is important to preserve muscle mass and to maintain myofiber integrity. Our results suggest that inhibition/alteration of autophagy can contribute to myofiber degeneration and weakness in muscle disorders characterized by accumulation of abnormal mitochondria and inclusions.

Skeletal muscle autophagy and apoptosis during aging: Effects of calorie restriction and life-long exercise

Sarcopenia, loss of muscle mass and function, is a common feature of aging. Oxidative damage and apoptosis are likely underlying factors. Autophagy, a process for the degradation of cellular constituents, may be a mechanism to combat cell damage and death. We investigated the effect of age on autophagy and apoptosis in plantaris muscle of male Fischer 344 rats that were either fed ad libitum, or mild, life-long calorie restricted (CR) alone or combined with life-long voluntary exercise. Upstream autophagy-regulatory proteins were either upregulated with age (Beclin-1) or unchanged (Atg7 and 9). LC3 gene and protein expression pattern as well as LAMP-2 gene expression, both downstream regulators of autophagy, however, suggested an age-related decline in autophagic degradation. Atg protein expression and LC3 and LAMP-2 gene expression were improved in CR rats with or without exercise. The age-related increase in oxidative damage and apoptosis were attenuated by the treatments. Both, oxidative damage and apoptosis correlated negatively with autophagy. We conclude that mild CR attenuates the age-related impairment of autophagy in rodent skeletal muscle, which might be one of the mechanisms by which CR attenuates age-related cellular damage and cell death in skeletal muscle in vivo.

FoxO Transcription Factors Promote Autophagy in Cardiomyocytes

In the heart, autophagy is required for normal cardiac function and also has been implicated in cardiovascular disease. FoxO transcription factors promote autophagy in skeletal muscle and have additional roles in regulation of cell size, proliferation, and metabolism. Here we investigate the role of FoxO transcription factors in regulating autophagy and cell size in cardiomyocytes. In cultured rat neonatal cardiomyocytes, glucose deprivation leads to decreased cell size and induction of autophagy pathway genes LC3, Gabarapl1, and Atg12. Likewise, overexpression of either FoxO1 or FoxO3 reduces cardiomyocyte cell size and induces expression of autophagy pathway genes. Moreover, inhibition of FoxO activity by dominant negative FoxO1 (Delta256) blocks cardiomyocyte cell size reduction upon starvation, suggesting the necessity of FoxO function in cardiomyocyte cell size regulation. Under starvation conditions, endogenous FoxO1 and FoxO3 are localized to the nucleus and bind to promoter sequences of Gabarapl1 and Atg12. In vivo studies show that cellular stress, such as starvation or ischemia/reperfusion in mice, results in induction of autophagy in the heart with concomitant dephosphorylation of FoxO, consistent with increased activity of nuclear FoxO transcription factors. Together these results provide evidence for an important role for FoxO1 and FoxO3 in regulating autophagy and cell size in cardiomyocytes.

Autophagy in skeletal muscle: The effects of age and diet

Effects of age and life‐long calorie restriction on regulation of autophagy were studied in skeletal muscle of male Fischer344xBrownNorway rats. Autophagy is the primary pathway for degradation of long‐lived proteins and organelles. We investigated the expression of autophagy regulatory proteins in plantaris (fast‐twitch) and soleus (slow‐twitch) muscles of 8, 27 and 38‐month‐old rats, fed ad libitum or 40% calorie restricted (CR). Muscle mass decreased with age. The decrease was less pronounced in soleus than plantaris, and attenuated by CR in both muscles. The expression of the autophagy regulatory proteins Beclin‐1 and Atg7 increased with age in both muscles. In contrast, the LC‐3 II/I ratio increased in the soleus, but decreased in the plantaris. CR stimulated autophagy in the soleus but had no marked effect in the plantaris. In conclusion, the response of autophagy to age and CR appears to be muscle type specific, with implications for autophagy's diverse roles in aging. This study was supported by the University of Florida Institute on Aging and Claude D. Pepper Older Americans Independence Center (1 P30 AG028740) and by grants to CL (NIA R01‐AG17994 and AG21042).

Examination of ‘lipotoxicity’ in skeletal muscle of high‐fat fed and ob/ob mice

Excess lipid accumulation resulting from an elevated supply of plasma fatty acids is linked to the pathogenesis of the metabolic syndrome and heart disease. The term 'lipotoxicity' was coined to describe how lipid accumulation leads to cellular dysfunction and death in non-adipose tissues including the heart, pancreas and liver. While lipotoxicity has been shown in cultured skeletal muscle cells, the degree of lipotoxicity in vivo and the functional consequences are unresolved. We studied three models of fatty acid overload in male mice: 5 h Intralipid((R)) and heparin infusion, prolonged high fat feeding (HFF) and genetic obesity induced by leptin deficiency (ob/ob mice). Markers of apoptosis, proteolysis and autophagy were assessed as readouts of lipotoxicity. The Intralipid((R)) infusion increased caspase 3 activity in skeletal muscle, demonstrating that enhancing fatty acid flux activates pro-apoptotic pathways. HFF and genetic obesity increased tissue lipid content but did not influence apoptosis. Gene array analysis revealed that HFF reduced the expression of 31 pro-apoptotic genes. Markers of autophagy (LC3beta and beclin-1 expression) were unaffected by HFF and were associated with enhanced Bcl(2) protein expression. Proteolytic activity was similarly unaffected by HFF or in ob/ob mice. Thus, contrary to our previous findings in muscle culture in vitro and in other non-adipose tissues in vivo, lipid overload did not induce apoptosis, autophagy or proteolysis in skeletal muscle. A broad transcriptional suppression of pro-apoptotic proteins may explain this resistance to lipid-induced cell death in skeletal muscle.

Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches

Lysosomes filled with glycogen are a major pathologic feature of Pompe disease, a fatal myopathy and cardiomyopathy caused by a deficiency of the glycogen-degrading lysosomal enzyme, acid α-glucosidase (GAA). To facilitate studies germane to this genetic disorder, we developed two in vitro Pompe models: myotubes derived from cultured primary myoblasts isolated from Pompe (GAA KO) mice, and myotubes derived from primary myoblasts of the same genotype that had been transduced with cyclin-dependent kinase 4 (CDK4). This latter model is endowed with extended proliferative capacity. Both models showed extremely large alkalinized, glycogen-filled lysosomes as well as impaired trafficking to lysosomes. Although both Pompe tissue culture models were derived from fast muscles and were fast myosin positive, they strongly resemble slow fibers in terms of their pathologic phenotype and their response to therapy with recombinant human GAA (rhGAA). Autophagic buildup, a hallmark of Pompe disease in fast muscle fibers, was absent, but basal autophagy was functional. To evaluate substrate deprivation as a strategy to prevent the accumulation of lysosomal glycogen, we knocked down Atg7, a gene essential for autophagosome formation, via siRNA, but we observed no effect on the extent of glycogen accumulation, thus confirming our recent observation in autophagy-deficient Pompe mice [N. Raben, V. Hill, L. Shea, S. Takikita, R. Baum, N. Mizushima, E. Ralston, P. Plotz, Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease, Hum. Mol. Genet. 17 (2008) 3897–3908] that macroautophagy is not the major route of glycogen transport to lysosomes. The in vitro Pompe models should be useful in addressing fundamental questions regarding the pathway of glycogen to the lysosomes and testing panels of small molecules that could affect glycogen biosynthesis or speed delivery of the replacement enzyme to affected lysosomes.

Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease

The role of autophagy, a catabolic lysosome-dependent pathway, has recently been recognized in a variety of disorders, including Pompe disease, the genetic deficiency of the glycogen-degrading lysosomal enzyme acid-alpha glucosidase. Accumulation of lysosomal glycogen, presumably transported from the cytoplasm by the autophagic pathway, occurs in multiple tissues, but pathology is most severe in skeletal and cardiac muscle. Skeletal muscle pathology also involves massive autophagic buildup in the core of myofibers. To determine if glycogen reaches the lysosome via autophagy and to ascertain whether autophagic buildup in Pompe disease is a consequence of induction of autophagy and/or reduced turnover due to defective fusion with lysosomes, we generated muscle-specific autophagy-deficient Pompe mice. We have demonstrated that autophagy is not required for glycogen transport to lysosomes in skeletal muscle. We have also found that Pompe disease involves induction of autophagy but manifests as a functional deficiency of autophagy because of impaired autophagosomal-lysosomal fusion. As a result, autophagic substrates, including potentially toxic aggregate-prone ubiquitinated proteins, accumulate in Pompe myofibers and may cause profound muscle damage.

FoxO3 Controls Autophagy in Skeletal Muscle In Vivo

Autophagy allows cell survival during starvation through the bulk degradation of proteins and organelles by lysosomal enzymes. However, the mechanisms responsible for the induction and regulation of the autophagy program are poorly understood. Here we show that the FoxO3 transcription factor, which plays a critical role in muscle atrophy, is necessary and sufficient for the induction of autophagy in skeletal muscle in vivo. Akt/PKB activation blocks FoxO3 activation and autophagy, and this effect is not prevented by rapamycin. FoxO3 controls the transcription of autophagy-related genes, including LC3 and Bnip3, and Bnip3 appears to mediate the effect of FoxO3 on autophagy. This effect is not prevented by proteasome inhibitors. Thus, FoxO3 controls the two major systems of protein breakdown in skeletal muscle, the ubiquitin-proteasomal and autophagic/lysosomal pathways, independently. These findings point to FoxO3 and Bnip3 as potential therapeutic targets in muscle wasting disorders and other degenerative and neoplastic diseases in which autophagy is involved.

Satellite cells derived from streptozotocin-diabetic rats display altered fusion parameters in vitro

Myogenic satellite cells were isolated from nondiabetic and streptozotocin-diabetic rats and studied in vitro. Streptozotocin (STZ) administration produced both hyperglucemia and glucosuria in adult rats when compared to controls. ( P < 0.01), with 12.5% mortality in untreated animals. Insulin therapy diminished blood glucose levels to those found in nondiabetic animals. Only STZ-diabetic rats displayed symptoms of Type I diabetes, including polydipsia, polyuria, and hyperphagia. STZ-treated rats possessed less leg muscle mass and less subcutaneous, intermuscular, and intramuscular fat. Conversely, nondiabetic rats had a greater mean body weight ( P < 0.01) at the end of the experiment than did diabetic rats. Primary cultures of diabetic-derived satellite cells displayed decreased overall ability ( P < 0.01) to fuse to form multinucleated myotubes in vitro than controls. In addition, secondary cultures of diabetic-derived satellite cells achieved maximal fusion one day later than secondary cultures of control-derived cells. Collectively, these data provide preliminary evidence to suggest that untreated insulin-dependent diabetes results in altered fusion characteristics of myogenic satellite cells. Additional studies utilizing satellite cells from diabetic animals will provide valuable definition of the satellite cell involvement in skeletal muscle autophagy which is a symptom of type I diabetes.